How to Help Your Patients Save Money on Triumeq: A Provider's Guide to Savings Programs

Triumeq (abacavir/dolutegravir/lamivudine) has a retail price of $3,900–$4,600 per month — a financial barrier that, without proper support systems in place, can lead patients to skip doses, ration medication, or abandon treatment altogether. Treatment interruption in HIV care carries serious clinical consequences. As a prescriber, proactively enrolling your patients in the right savings programs at the time of initiation is one of the most impactful things you can do for their long-term health outcomes.

This guide covers every major financial support pathway available for Triumeq in 2026, along with practical enrollment steps for each.

Program 1: ViiVConnect Savings Card (Commercially Insured Patients)

The ViiVConnect Savings Card is the primary manufacturer-sponsored copay assistance program for Triumeq. Key details for providers:

Benefit: Eligible commercially insured patients may pay $0 per prescription fill, with up to $7,500 per year in manufacturer copay support.

Eligibility: Commercially insured patients only (not Medicare or Medicaid). No income restriction for the savings card.

Enrollment: viivconnect.com or 1-844-588-3288. Patients or providers can enroll online, by phone, or through the HCP portal. HCP enrollment options include download/fax/mail, HCP portal, or the online microsite.

Rebate option: If a patient's pharmacy does not accept the savings card directly, eligible patients may submit a rebate for reimbursement.

Best practice: Enroll patients in ViiVConnect at the time of the first prescription — don't wait for a refill crisis. Ensure your office coordinator or MA is familiar with the enrollment process.

Program 2: ViiV Patient Assistance Program (Uninsured / Underinsured Patients)

For patients who are uninsured or have limited incomes, ViiV Healthcare's Patient Assistance Program (PAP) can provide Triumeq at no cost.

Eligibility: Uninsured patients with limited incomes; income thresholds apply. U.S. residency and Social Security number required.

Application: Via viivconnect.com or 1-844-588-3288. Applications can be submitted by mail, fax, or online. Provider signature required.

Processing time: Allow 2–4 weeks for new applications. ViiVConnect may offer bridge supplies in some cases while applications are processed.

Program 3: AIDS Drug Assistance Programs (ADAP)

State AIDS Drug Assistance Programs (ADAP), funded through the federal Ryan White HIV/AIDS Program, are the most important public-sector financial safety net for HIV medication access. ADAP programs exist in all 50 states and typically cover Triumeq for low-income patients with HIV.

Benefit: Triumeq at little to no out-of-pocket cost for eligible patients

Eligibility: Income-based; varies by state. Most programs cover patients up to 300–400% of federal poverty level.

Additional benefit: ADAP programs typically route medications through specialty pharmacies, improving both access and adherence support for your patients.

Contact your state health department or refer patients to your clinic's social worker / patient navigator for ADAP enrollment assistance. The National Alliance of State & Territorial AIDS Directors (NASTAD) maintains a searchable ADAP database.

Program 4: PAN Foundation (Insured Patients with High Copays)

The PAN Foundation (Patient Advocate Foundation) provides copay assistance for insured patients who still face high out-of-pocket costs despite having coverage. This is particularly relevant for patients whose insurance does not accept the ViiVConnect Savings Card.

Eligibility: Must have insurance and a valid prescription. Income criteria apply.

Application: panfoundation.org or 1-866-316-7263

Program 5: HarborPath ADAP Waiting List Program

For patients who are on a state ADAP waiting list and cannot immediately access medications, the HarborPath ADAP Waiting List Program provides bridge access to medications including Triumeq. Patients must have confirmation from their state ADAP that they are on the waiting list. Contact 877-968-7233 or visit the program website for more information.

Medicare Patients: Part D Optimization

Manufacturer copay cards cannot be used with Medicare. For Medicare patients on Triumeq:

The Part D $2,000 annual out-of-pocket cap (effective 2025) provides significant protection — once reached, the plan covers 100% of covered drugs for the remainder of the year.

The Medicare Prescription Payment Plan allows patients to spread OOP costs across the year rather than paying upfront.

Low-Income Subsidy (LIS / Extra Help) from Social Security Administration may reduce Part D costs significantly for qualifying Medicare patients.

Provider Action Checklist: Savings at Triumeq Initiation

Confirm insurance status and identify the appropriate savings pathway before writing the first prescription

Enroll commercially insured patients in ViiVConnect Savings Card on Day 1

Refer uninsured/low-income patients to ViiV PAP or ADAP with your clinic social worker's support

For high-copay insured patients, explore PAN Foundation or other co-pay foundations

Route prescription to HIV specialty pharmacy at enrollment — do not default to retail chain

Prescribe 90-day supply when insurance permits

Helping Patients Who Have Trouble Finding Triumeq

Beyond cost, some patients struggle to locate Triumeq at their pharmacy. Refer them to medfinder.com/providers — a service that calls pharmacies near your patient to check current stock and texts results directly. This reduces calls to your office and helps patients access their medication without delay.

See also: Triumeq shortage and availability: What providers need to know in 2026.